Stock listing

OTC:MDNC Medinotec Inc. Stock

Follow Medinotec Inc. into a list and get an email when it puts out news.

Share price · OTC:MDNC

$5.00 USD 0.00 (0.0%)

Close on Oct 23, 2026

Past year 0.0% · daily closes, Oct 23, 2025 – Oct 23, 2026, adjusted for splits
Day range
$5.00 – $5.00 USDOct 23, 2026
Market cap
—Left out: too few shares trade to back it
52-week range
$5.00 – $5.00 USDLowest and highest trades, Oct 24, 2025 – Oct 23, 2026
Traded on an average day
$0 USDMedian day 0 shares · 66 days with no trades · last 3 months, Jul 23, 2026 – Oct 23, 2026
Medinotec Inc. logo

Daily closes

Last 3 months, Jul 23, 2026 – Oct 23, 2026 · OTC:MDNC · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
$5.000.000.0%$5.00$5.00$5.000
Ticker
OTC:MDNC
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
OTC
Currency
USD

Latest news

All Medinotec Inc. news

Medinotec Inc. on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
4 in all · newest Jun 23, 2023 · oldest 2023

Valuation

Statements: 4 quarters to Aug 31, 2026 · price Oct 23, 2026

Enterprise value
No market cap
P/E
No market cap
EV/sales
No market cap
EV/EBITDA
No market cap
Price/book
No market cap
Gross margin
49.9%
Operating margin
6.6%
Net margin
5.9%
Debt to equity
0.0×
Beta vs S&P 500
0.00

Team and board

OfficerRole
Gregory VizirgianakisGroup Chief Executive Officer
Pieter van NiekerkGroup Chief Financial Officer

Financials

Annual, in USD

Income statement

LineFY2026FY2025FY2024FY2023
Revenue9.73M9.11M5.02M999.6K
Cost of revenue4.60M4.30M-2.58M-417.8K
Gross profit5.13M4.82M2.44M581.8K
Research and development149.9K91.1K-22.4K-64.9K
Operating income1.09M3.19M600.6K-238.6K
Depreciation and amortization80.9K73.8K88.2K53.6K
EBITDA1.18M3.27M688.8K-185.0K
Interest expense87.6K176.4K-277.2K-226.8K
Income before tax1.07M3.02M-253.8K-391.5K
Income tax-274.7K-864.7K-150.9K38.7K
Net income794.5K2.16M-404.7K-352.7K
Earnings per share, basic0.070.18-0.03-0.03

Balance sheet

LineFY2026FY2025FY2024FY2023
Cash and equivalents2.76M2.77M2.81M2.83M
Receivables2.35M2.61M589.8K21.1K
Current assets6.42M6.42M4.38M3.37M
Property, plant and equipment331.3K348.5K320.1K406.9K
Total assets6.81M6.81M4.80M4.49M
Current liabilities1.10M1.51M827.5K71.3K
Total liabilities1.10M2.54M2.64M1.93M
Shareholders' equity5.71M4.27M2.17M2.56M
Shares outstanding11.8M11.7M11.7M11.7K

Cash flow

LineFY2026FY2025FY2024FY2023
Cash from operations906.8K877.8K14.2K-490.5K
Capital spending-1.36K-89.0K-2.25K-55.3K
Free cash flow905.4K788.8K12.0K-545.8K
Cash from investing-1.36K-89.0K10.1K-529.7K
Cash from financing-983.0K-894.5K-8.09K3.58M
Change in cash-12.7K-39.2K-18.5K2.70M

Open Financials

Filings

FilingDateTypeFiled with
10-Q · Quarterly reportOct 8, 2026Quarterly reportSEC
10-Q · Quarterly reportJul 9, 2026Quarterly reportSEC
10-K · Annual reportMay 28, 2026Annual reportSEC
8-K · Current reportJan 20, 2026Meeting outcomeSEC
10-Q · Quarterly reportJan 9, 2026Quarterly reportSEC
DEF 14A · Proxy statementJan 2, 2026Meeting noticeSEC
10-Q · Quarterly reportOct 8, 2025Quarterly reportSEC
10-Q · Quarterly reportJul 16, 2025Quarterly reportSEC
NT 10-Q · Late filing noticeJul 16, 2025Explanation requestSEC
3 · Initial statement of ownershipJun 17, 2025Insider tradeSEC
All 54 filings
FilingDateTypeFiled with
SCHEDULE 13D · Big-stake noticeJun 12, 2025Big-stake noticeSEC
SCHEDULE 13D · Big-stake noticeJun 12, 2025Big-stake noticeSEC
3 · Initial statement of ownershipJun 12, 2025Insider tradeSEC
3 · Initial statement of ownershipJun 12, 2025Insider tradeSEC
10-K · Annual reportMay 29, 2025Annual reportSEC
3 · Initial statement of ownershipMay 22, 2025Insider tradeSEC
3 · Initial statement of ownershipMay 22, 2025Insider tradeSEC
8-A12G · Registration of a class of sharesApr 16, 2025Other filingsSEC
8-K · Current reportJan 27, 2025Current reportSEC
10-Q · Quarterly reportJan 14, 2025Quarterly reportSEC
10-Q · Quarterly reportOct 15, 2024Quarterly reportSEC
10-Q · Quarterly reportJul 12, 2024Quarterly reportSEC
8-K · Current reportJul 10, 2024Current reportSEC
10-K · Annual reportJul 3, 2024Annual reportSEC
NT 10-K · Late filing noticeMay 29, 2024Explanation requestSEC
8-K · Current reportMar 19, 2024Meeting outcomeSEC
10-Q · Quarterly reportMar 14, 2024Quarterly reportSEC
8-K · Current reportFeb 26, 2024Current reportSEC
NT 10-Q · Late filing noticeJan 12, 2024Explanation requestSEC
10-Q · Quarterly reportOct 13, 2023Quarterly reportSEC
8-K · Current reportOct 12, 2023Management or board changeSEC
10-Q · Quarterly reportJul 14, 2023Quarterly reportSEC
8-K · Current reportJun 21, 2023Current reportSEC
10-K · Annual reportMay 30, 2023Annual reportSEC
8-K · Current reportMay 17, 2023Current reportSEC
8-K · Current reportMar 31, 2023Current reportSEC
8-K · Current reportMar 22, 2023Current reportSEC
8-K · Current reportMar 13, 2023Current reportSEC
8-K · Current reportFeb 8, 2023ResultsSEC
8-K · Current reportJan 19, 2023ResultsSEC
10-Q · Quarterly reportJan 17, 2023Quarterly reportSEC
EFFECT · Notice that a registration is effectiveDec 2, 2022Other filingsSEC
CORRESP · Letter to the SECNov 29, 2022Other filingsSEC
S-1/A · Registration statement, amendedNov 18, 2022Offer documentSEC
UPLOAD · Letter from the SECNov 14, 2022Other filingsSEC
S-1/A · Registration statement, amendedNov 2, 2022Offer documentSEC
UPLOAD · Letter from the SECOct 13, 2022Other filingsSEC
S-1/A · Registration statement, amendedSep 29, 2022Offer documentSEC
UPLOAD · Letter from the SECSep 15, 2022Other filingsSEC
S-1/A · Registration statement, amendedAug 30, 2022Offer documentSEC
UPLOAD · Letter from the SECAug 18, 2022Other filingsSEC
S-1/A · Registration statement, amendedAug 4, 2022Offer documentSEC
UPLOAD · Letter from the SECJun 28, 2022Other filingsSEC
S-1 · Registration statementJun 2, 2022Offer documentSEC

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Medinotec Inc.’s releases · as of Oct 8, 2026

Common shares
11,755,548
Fully diluted
11,755,548

Fully diluted

LineSharesAs of
Common shares11,755,548Oct 8, 2026

Share count over time

CountShares
Oct 8, 202611,755,548

Open Cap table

Shareholders

StakeStakeSharesDateFiling
Gregory Vizirgianakis40.40%4.75MApr 16, 2025Schedule 13D
Stavros G. Vizirgianakis40.40%4.75MApr 16, 2025Schedule 13D

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Stavros G. Vizirgianakis
Other companies: Apyx Medical Corporation (Chairman of the Board · Since at least May 7, 2024); Xtant Medical Holdings, Inc. (Director · Since at least Aug 25, 2022); Bioventus Inc. (Director · Oct 29, 2021 – Jun 16, 2022 · Past); Misonix Inc (President and CEO, Director · May 7, 2013 – Oct 29, 2021 · Past)
Director · Apr 16, 2025 – Apr 16, 2025 · Past
Gregory VizirgianakisGroup Chief Executive Officer · Since at least Apr 16, 2025
Pieter van NiekerkGroup Chief Financial Officer · Since at least Apr 16, 2025

Open People

Log in to ask 6ix AI your own questions about Medinotec Inc.